FIELD: medicine.
SUBSTANCE: invention relates to new heterocyclic compounds having the general formula (Ic), as well as to compositions comprising these compounds, methods for the manufacture of these compounds and methods of using these compounds.
EFFECT: new compounds have been obtained that can be used to inhibit the activity of monoacylglycerol lipase (MAGL).
44 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2769507C1 |
| NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2801190C2 |
| HETEROCYCLIC COMPOUNDS | 2019 |
|
RU2809257C2 |
| SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS | 2013 |
|
RU2690663C2 |
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
| HETEROCYCLIC COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2667498C2 |
| PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
| NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
| COMPOUND 8-FLUOROPHTHALAZINE-1(2H)-ONE AS INHIBITORS OF BRUTON TYROSINE KINASE | 2012 |
|
RU2622391C2 |
| PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
